MimiVax, Inc.

Mimivax, inc. email format

Verified email-pattern data for Mimivax, Inc. is currently limited. You can still use the company insights and contact sections below.
Our vision, to disrupt cancer with the development of highly innovative immunotherapies aimed at increasing patient survival rates MimiVax is a privately held, clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. SurVaxM, our lead immunotherapeutic vaccine, has completed a Phase 2a clinical trial in adults with newly diagnosed glioblastoma. Additional indications are being evaluated through: - Phase 1 clinical trials in multiple myeloma combination with REVLIMID® (lenalidomide) - Phase 1 in Neuro-Endocrine Tumors (NET) - Pilot Study in Pediatric High Grade Glioma, recurrent/relapsed Medulloblastoma and DIPG
Looking for a particular MimiVax, Inc. employee's phone or email?

Mimivax, Inc. Questions

Explore related pages

Related company profiles:

Top MimiVax, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant